Organizational Impact of Immunotherapies in Advanced Cancers in France.
Valentine GrumbergChristos ChouaidAnne-Françoise GaudinChristophe Le TourneauAurélien MarabelleIsabelle Bongiovanni-DelarozièreFrançois-Emery CottéIsabelle BorgetPublished in: JCO global oncology (2023)
The introduction of immunotherapies for advanced cancer has had an important OI in France, regarding capacities and skills. Further research using qualitative analysis of interviews will provide more information regarding OI.